Antoniskis D, Larsen R A
Los Angeles County-University of Southern California Medical Center 90033.
Antimicrob Agents Chemother. 1990 Mar;34(3):470-2. doi: 10.1128/AAC.34.3.470.
We report four cases of acute reversible renal failure in patients with acquired immune deficiency syndrome who received both amphotericin B (for systemic mycoses) and pentamidine isethionate (for Pneumocystis carinii pneumonia). The concurrent use of amphotericin B with either inhaled pentamidine or trimethoprim-sulfamethoxazole did not cause significant renal impairment.